Investors

Date	Name	Title	Type	Shares Traded	Price Range
Oct 1, 2008	mccorkle douglas s	Officer	Automatic Sell	6,262	21.31 - 22.18
Oct 1, 2008	mccorkle douglas s	Officer	Sell	79	21.24
Oct 1, 2008	mccorkle douglas s	Officer	Option Execute	4,957	8.50 - 11.64
Oct 1, 2008	mccorkle douglas s	Officer	Automatic Sell	4,957	21.22 - 21.60
Oct 1, 2008	mccorkle douglas s	Officer	Option Execute	5,034	8.50 - 13.00
Oct 1, 2008	mccorkle douglas s	Officer	Automatic Sell	5,034	21.22 - 22.16
Nov 2, 2007	mccorkle douglas s	Officer	Option Execute	6,209	8.50 - 9.49
Nov 2, 2007	mccorkle douglas s	Officer	Automatic Sell	6,209	21.00 - 21.03
Sep 1, 2011	larosa joseph j	Officer	Acquisition (Non Open Market)	10,000	n/a
Jun 3, 2010	kolinski stuart	Officer	Option Execute	12,500	8.50
Jun 3, 2010	kolinski stuart	Officer	Automatic Sell	6,784	30.02
Feb 3, 2010	kolinski stuart	Officer	Automatic Sell	5,401	27.66 - 28.08
Feb 2, 2010	kolinski stuart	Officer	Option Execute	12,314	8.50
Feb 2, 2010	kolinski stuart	Officer	Automatic Sell	6,913	27.16
Jan 27, 2010	kolinski stuart	Officer	Option Execute	4,359	8.50
Jan 27, 2010	kolinski stuart	Officer	Automatic Sell	4,359	27.00
Sep 19, 2008	kolinski stuart	Officer	Option Execute	9,992	8.50
Sep 19, 2008	kolinski stuart	Officer	Sell	9,992	23.40 - 23.69
May 20, 2013	goldstein joseph l	Director	Acquisition (Non Open Market)	4,000	n/a
Apr 1, 2013	goldstein joseph l	Director	Option Execute	5,000	24.41
Showing 361-380 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.